PSC

Patient Square Capital Portfolio holdings

AUM $277M
1-Year Est. Return 6.76%
This Quarter Est. Return
1 Year Est. Return
+6.76%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$242M
AUM Growth
-$25.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
24
New
Increased
Reduced
Closed

Top Buys

1
+$3.92M
2
+$3.89M
3
+$3.41M
4
OCUL icon
Ocular Therapeutix
OCUL
+$3.29M
5
MIRM icon
Mirum Pharmaceuticals
MIRM
+$2.32M

Top Sells

1
+$6.01M
2
+$4.98M
3
+$4.68M
4
SWTX
SpringWorks Therapeutics
SWTX
+$3.37M
5
ARVN icon
Arvinas
ARVN
+$1.66M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROIV icon
1
Roivant Sciences
ROIV
$12.4B
$126M 52.09%
12,480,000
INSM icon
2
Insmed
INSM
$33.7B
$25.2M 10.42%
330,250
+23,083
LQDA icon
3
Liquidia Corp
LQDA
$1.93B
$22.5M 9.29%
1,522,452
-337,919
EYPT icon
4
EyePoint Pharmaceuticals
EYPT
$967M
$8.03M 3.32%
1,481,977
+71,646
OCUL icon
5
Ocular Therapeutix
OCUL
$2.43B
$6.75M 2.79%
920,199
+449,280
CGEM icon
6
Cullinan Oncology
CGEM
$458M
$6.65M 2.75%
878,897
NRIX icon
7
Nurix Therapeutics
NRIX
$1.12B
$5.31M 2.2%
447,296
+1,000
MIRM icon
8
Mirum Pharmaceuticals
MIRM
$3.52B
$5.24M 2.17%
116,362
+51,462
ELVN icon
9
Enliven Therapeutics
ELVN
$1.22B
$5M 2.07%
253,838
+29,800
SRRK icon
10
Scholar Rock
SRRK
$2.85B
$4.95M 2.05%
154,000
+122,000
IRON icon
11
Disc Medicine
IRON
$3.2B
$4.12M 1.7%
83,000
+26,600
AGIO icon
12
Agios Pharmaceuticals
AGIO
$2.52B
$4.09M 1.69%
139,732
+18,000
KYMR icon
13
Kymera Therapeutics
KYMR
$4.19B
$3.89M 1.61%
+142,201
PHVS icon
14
Pharvaris
PHVS
$1.48B
$3.85M 1.59%
245,496
+37,893
ALLO icon
15
Allogene Therapeutics
ALLO
$266M
$3.46M 1.43%
2,368,186
+878,277
BPMC
16
DELISTED
Blueprint Medicines
BPMC
$3.41M 1.41%
+38,500
NTLA icon
17
Intellia Therapeutics
NTLA
$2.75B
$1.66M 0.68%
232,781
+16,800
SLNO icon
18
Soleno Therapeutics
SLNO
$3.41B
$1.33M 0.55%
+18,600
VYNE icon
19
VYNE Therapeutics
VYNE
$9.51M
$406K 0.17%
+257,033
ARVN icon
20
Arvinas
ARVN
$676M
– –
-86,627
ATXS icon
21
Astria Therapeutics
ATXS
$702M
– –
-105,057
GERN icon
22
Geron
GERN
$791M
– –
-1,321,268
SWTX
23
DELISTED
SpringWorks Therapeutics
SWTX
– –
-93,137
ITCI
24
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-71,990